Literature DB >> 16414036

The activation-induced expression of DHX32 in Jurkat T cells is specific and involves calcium and nuclear factor of activated T cells.

Zaman Alli1, Eric H Nam, Kassa Beimnet, Mohamed Abdelhaleem.   

Abstract

In this report, we studied DHX32 expression in human Jurkat T cells. Co-stimulation of CD3 and CD28 resulted in upregulation of DHX32. No significant changes in the expression of the closely related RNA helicases were seen. Ionomycin treatment alone was sufficient to upregulate the expression of DHX32 mRNA isoform transcribed from the proximal promoter. We cloned DHX32 proximal promoter and identified a 218bp fragment containing two potential binding sites for the transcription factor nuclear factor of activated T cells (NF-AT). Mutation of core sequence of NF-AT resulted in reduced transcriptional activity, with more reduction observed in the second NF-AT site. Electrophoretic mobility shift assay results were consistent with a specific binding of NF-AT from ionomycin stimulated nuclear extract of Jurkat cells to oligonucleotide probes from DHX32 proximal promoter. These results suggest that the DHX32 expression is modulated in Jurkat T cells via a pathway that involves NF-AT.

Entities:  

Mesh:

Substances:

Year:  2005        PMID: 16414036     DOI: 10.1016/j.cellimm.2005.12.003

Source DB:  PubMed          Journal:  Cell Immunol        ISSN: 0008-8749            Impact factor:   4.868


  3 in total

1.  Variation at FCGR2A and functionally related genes is associated with the response to anti-TNF therapy in rheumatoid arthritis.

Authors:  Gabriela Avila-Pedretti; Jesús Tornero; Antonio Fernández-Nebro; Francisco Blanco; Isidoro González-Alvaro; Juan D Cañete; Joan Maymó; Mercedes Alperiz; Benjamín Fernández-Gutiérrez; Alex Olivé; Héctor Corominas; Alba Erra; Adrià Aterido; María López Lasanta; Raül Tortosa; Antonio Julià; Sara Marsal
Journal:  PLoS One       Date:  2015-04-07       Impact factor: 3.240

2.  A human XPC protein interactome--a resource.

Authors:  Abigail Lubin; Ling Zhang; Hua Chen; Victoria M White; Feng Gong
Journal:  Int J Mol Sci       Date:  2013-12-23       Impact factor: 5.923

3.  Silencing of DHX32 increases the proliferation of liver cancer cells.

Authors:  Min-Jing Cai; Jian-Hui Zhu; Jian-Quan He; Zhong-Ying Zhang; Xian-Ming Liang
Journal:  Transl Cancer Res       Date:  2020-03       Impact factor: 1.241

  3 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.